Items where Author is "Dianat-Moghadam, H."

(2025) Autophagy-based therapy for hepatocellular carcinoma: from standard treatments to combination therapy, oncolytic virotherapy, and targeted nanomedicines. Clinical and Experimental Medicine. ISSN 15918890 (ISSN)

(2025) GLP-1-based therapies for type 2 diabetes: from single, dual and triple agonists to endogenous GLP-1 production and L-cell differentiation. Diabetology & Metabolic Syndrome. p. 27.

(2025) Single cell RNA sequencing improves the next generation of approaches to AML treatment: challenges and perspectives. Molecular Medicine. p. 26. ISSN 1076-1551

(2025) Therapeutic and prognostic values of ferroptosis signature in glioblastoma. International Immunopharmacology. p. 114597. ISSN 1878-1705 (Electronic) 1567-5769 (Linking)

(2024) Autophagy-based therapy for hepatocellular carcinoma: from standard treatments to combination therapy, oncolytic virotherapy, and targeted nanomedicines. Clinical and Experimental Medicine. p. 23. ISSN 1591-8890

(2024) Deciphering the multifaceted role of microRNAs in hepatocellular carcinoma: Integrating literature review and bioinformatics analysis for therapeutic insights. Heliyon. e39489. ISSN 2405-8440 (Print) 2405-8440 (Electronic) 2405-8440 (Linking)

(2024) Exploring the Potential of Montmorillonite as an Antiproliferative Nanoagent against MDA-MB-231 and MCF-7 Human Breast Cancer Cells. Cells. p. 12.

(2024) Fabrication and characterization smart gold-polymer nanostructure as promising theranostic agent for dual-imaging and chemo-photothermal therapy of cancer: An in vitro study. Journal of Photochemistry and Photobiology a-Chemistry. p. 18. ISSN 1010-6030

(2024) From classical approaches to new developments in genetic engineering of live attenuated vaccine against cutaneous leishmaniasis: potential and immunization. Frontiers in Public Health. p. 12.

(2024) Green synthesis of MnO2 NPs using Arabic gum: assessing its potential antiviral activity against influenza A/H1N1. Virology Journal. p. 10.

(2024) Oncolytic virotherapy improves immunotherapies targeting cancer stemness in glioblastoma. Biochimica Et Biophysica Acta-General Subjects. p. 9. ISSN 0304-4165

(2023) Engaging stemness improves cancer immunotherapy. Cancer letters. p. 216007. ISSN 1872-7980 (Electronic) 0304-3835 (Linking)

(2023) Immunotherapies targeting tumor vasculature: challenges and opportunities. Frontiers in Immunology. p. 12. ISSN 1664-3224

(2023) LXR inhibitor SR9243-loaded immunoliposomes modulate lipid metabolism and stemness in colorectal cancer cells. Medical Oncology. p. 14. ISSN 1357-0560

(2023) Resveratrol as an antitumor agent for glioblastoma multiforme: Targeting resistance and promoting apoptotic cell deaths. Acta Histochemica. p. 12. ISSN 0065-1281

(2023) Unraveling the potential of M13 phages in biomedicine: Advancing drug nanodelivery and gene therapy. Environmental Research. p. 20. ISSN 0013-9351

(2023) A review on the effect of nanocomposite scaffolds reinforced with magnetic nanoparticles in osteogenesis and healing of bone injuries. Stem Cell Research & Therapy. p. 17.

(2022) Antibacterial activity of green gold and silver nanoparticles using ginger root extract. Bioprocess and Biosystems Engineering. pp. 1905-1917. ISSN 1615-7591

(2022) Application of cell free DNA in ART. PLACENTA. pp. 18-24. ISSN 0143-4004 1532-3102 J9 - PLACENTA

(2022) Immune evader cancer stem cells direct the perspective approaches to cancer immunotherapy. STEM CELL RESEARCH & THERAPY. ISSN 1757-6512 J9 - STEM CELL RES THER

(2022) Isolation of cfDNA from spent culture media and its association with implantation rate and maternal immunomodulation. BMC RESEARCH NOTES. ISSN 1756-0500 J9 - BMC RES NOTES

(2022) MicroRNAs regulating Wnt signaling pathway in colorectal cancer: biological implications and clinical potentials. Functional & Integrative Genomics. pp. 1073-1088. ISSN 1438-793X

(2022) Multifunctional Plant Virus Nanoparticles for Targeting Breast Cancer Tumors. Vaccines. p. 16.

(2022) Oncolytic virus delivery modulated immune responses toward cancer therapy: Challenges and perspectives. International Immunopharmacology. p. 108882. ISSN 1878-1705 (Electronic) 1567-5769 (Linking)

(2022) Oncolytic virus delivery modulated immune responses toward cancer therapy: Challenges and perspectives. INTERNATIONAL IMMUNOPHARMACOLOGY. ISSN 1567-5769 1878-1705 J9 - INT IMMUNOPHARMACOL

(2022) PCL/Col I-based magnetic nanocomposite scaffold provides an osteoinductive environment for ADSCs in osteogenic cues-free media conditions. STEM CELL RESEARCH & THERAPY. ISSN 1757-6512 J9 - STEM CELL RES THER

(2020) Oncolytic Newcastle disease virus delivered by Mesenchymal stem cells-engineered system enhances the therapeutic effects altering tumor microenvironment. Virology Journal.

(2018) miRNA-based strategy for modulation of influenza A virus infection. Epigenomics. pp. 829-844. ISSN 1750-1911